MedTrace Logo

Observational Study of BIS in Hemodialysis Patients

NCT05381961 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-09-28

No results posted yet for this study

Summary

This observational study will evaluate bioimpedance spectroscopy (BIS) measurements from patients undergoing hemodialysis.

Conditions

  • Kidney Failure, Chronic
  • Renal Failure Chronic
  • Hemodialysis

Interventions

DEVICE

Bioimpedance spectroscopy (BIS) measurement, SOZO device

All patients enrolled in this study will undergo BIS measurement before and after 12 hemodialysis sessions (pre-dialysis and post-dialysis BIS measurements for each session). Measurements are not provided to treating physicians and are not used to guide clinical decisions; i.e., BIS measurements are collected for observational purposes only.

Sponsors & Collaborators

  • California Institute of Renal Research

    collaborator OTHER

  • Frenova Renal Research

    collaborator OTHER

  • ImpediMed Limited

    lead INDUSTRY

Principal Investigators

  • Mark Boiskin, MD · Balboa Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2022-11-08
Completion
2023-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05381961 on ClinicalTrials.gov